233 related articles for article (PubMed ID: 26482766)
1. Adherence to oral anticoagulants in patients with atrial fibrillation-a population-based retrospective cohort study linking health information systems in the Valencia region, Spain: a study protocol.
Sanfélix-Gimeno G; Rodríguez-Bernal CL; Hurtado I; Baixáuli-Pérez C; Librero J; Peiró S
BMJ Open; 2015 Oct; 5(10):e007613. PubMed ID: 26482766
[TBL] [Abstract][Full Text] [Related]
2. Primary Nonadherence to Oral Anticoagulants in Patients with Atrial Fibrillation: Real-World Data from a Population-Based Cohort.
Rodriguez-Bernal CL; Peiró S; Hurtado I; García-Sempere A; Sanfélix-Gimeno G
J Manag Care Spec Pharm; 2018 May; 24(5):440-448. PubMed ID: 29694286
[TBL] [Abstract][Full Text] [Related]
3. Real-world adherence to oral anticoagulants in atrial fibrillation patients: a study protocol for a systematic review and meta-analysis.
Rodríguez-Bernal CL; García-Sempere A; Hurtado I; Santa-Ana Y; Peiró S; Sanfélix-Gimeno G
BMJ Open; 2018 Dec; 8(12):e025102. PubMed ID: 30573490
[TBL] [Abstract][Full Text] [Related]
4. Comparative effectiveness and safety of oral anticoagulants for atrial fibrillation in real-world practice: a population-based cohort study protocol.
Holbrook A; Dormuth C; Morrow R; Lee A; Troyan S; Li G; Pullenyegum E
BMJ Open; 2016 Nov; 6(11):e013263. PubMed ID: 27884850
[TBL] [Abstract][Full Text] [Related]
5. Oral Anticoagulant Prescription Trends, Profile Use, and Determinants of Adherence in Patients with Atrial Fibrillation.
Perreault S; de Denus S; White-Guay B; Côté R; Schnitzer ME; Dubé MP; Dorais M; Tardif JC
Pharmacotherapy; 2020 Jan; 40(1):40-54. PubMed ID: 31758592
[TBL] [Abstract][Full Text] [Related]
6. Adherence and outcomes to direct oral anticoagulants among patients with atrial fibrillation: findings from the veterans health administration.
Borne RT; O'Donnell C; Turakhia MP; Varosy PD; Jackevicius CA; Marzec LN; Masoudi FA; Hess PL; Maddox TM; Ho PM
BMC Cardiovasc Disord; 2017 Sep; 17(1):236. PubMed ID: 28865440
[TBL] [Abstract][Full Text] [Related]
7. Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry.
Lip GY; Laroche C; Popescu MI; Rasmussen LH; Vitali-Serdoz L; Dan GA; Kalarus Z; Crijns HJ; Oliveira MM; Tavazzi L; Maggioni AP; Boriani G
Europace; 2015 Dec; 17(12):1777-86. PubMed ID: 26321406
[TBL] [Abstract][Full Text] [Related]
8. Use of oral anticoagulants in older people with atrial fibrillation in UK general practice: protocol for a cohort study using the Clinical Practice Research Datalink (CPRD) database.
Mitchell A; Welsh TJ; Watson MC; Snowball J; McGrogan A
BMJ Open; 2019 Dec; 9(12):e032646. PubMed ID: 31843842
[TBL] [Abstract][Full Text] [Related]
9. Estimating Adherence Based on Prescription or Dispensation Information: Impact on Thresholds and Outcomes. A Real-World Study With Atrial Fibrillation Patients Treated With Oral Anticoagulants in Spain.
Hurtado-Navarro I; García-Sempere A; Rodríguez-Bernal C; Santa-Ana-Tellez Y; Peiró S; Sanfélix-Gimeno G
Front Pharmacol; 2018; 9():1353. PubMed ID: 30559661
[No Abstract] [Full Text] [Related]
10. Trajectories of Oral Anticoagulation Adherence Among Medicare Beneficiaries Newly Diagnosed With Atrial Fibrillation.
Hernandez I; He M; Chen N; Brooks MM; Saba S; Gellad WF
J Am Heart Assoc; 2019 Jun; 8(12):e011427. PubMed ID: 31189392
[TBL] [Abstract][Full Text] [Related]
11. Murcia atrial fibrillation project II: protocol for a prospective observational study in patients with atrial fibrillation.
Rivera-Caravaca JM; Marín F; Esteve-Pastor MA; Gálvez J; Lip GYH; Vicente V; Roldán V
BMJ Open; 2019 Dec; 9(12):e033712. PubMed ID: 31843852
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Treatment Persistence with Dabigatran or Rivaroxaban versus Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients: A Competing Risk Analysis in the French National Health Care Databases.
Maura G; Billionnet C; Alla F; Gagne JJ; Pariente A
Pharmacotherapy; 2018 Jan; 38(1):6-18. PubMed ID: 29028119
[TBL] [Abstract][Full Text] [Related]
13. Real-World Adherence and Persistence with Direct Oral Anticoagulants in Adults with Atrial Fibrillation.
Manzoor BS; Lee TA; Sharp LK; Walton SM; Galanter WL; Nutescu EA
Pharmacotherapy; 2017 Oct; 37(10):1221-1230. PubMed ID: 28730619
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the short-term risk of bleeding and arterial thromboembolic events in nonvalvular atrial fibrillation patients newly treated with dabigatran or rivaroxaban versus vitamin K antagonists: a French nationwide propensity-matched cohort study.
Maura G; Blotière PO; Bouillon K; Billionnet C; Ricordeau P; Alla F; Zureik M
Circulation; 2015 Sep; 132(13):1252-60. PubMed ID: 26199338
[TBL] [Abstract][Full Text] [Related]
15. Prediction of individual combined benefit and harm for patients with atrial fibrillation considering warfarin therapy: a study protocol.
Li G; Holbrook A; Delate T; Witt DM; Levine MA; Thabane L
BMJ Open; 2015 Nov; 5(11):e009518. PubMed ID: 26546146
[TBL] [Abstract][Full Text] [Related]
16. Therapy persistence in newly diagnosed non-valvular atrial fibrillation treated with warfarin or NOAC. A cohort study.
Martinez C; Katholing A; Wallenhorst C; Freedman SB
Thromb Haemost; 2016 Jan; 115(1):31-9. PubMed ID: 26246112
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness and safety of drugs used for stroke prevention in a cohort of non-valvular atrial fibrillation patients from a primary care electronic database.
Giner-Soriano M; Roso-Llorach A; Vedia Urgell C; Castells X; Capellà D; Ferreira-González I; Elorza-Ricart JM; Casajuana M; Troncoso Mariño A; Diògene E; Bolíbar B; Violan C; Morros R
Pharmacoepidemiol Drug Saf; 2017 Jan; 26(1):97-107. PubMed ID: 27868275
[TBL] [Abstract][Full Text] [Related]
18. The use and adherence of oral anticoagulants in Primary Health Care in Catalunya, Spain: A real-world data cohort study.
Giner-Soriano M; Cortes J; Gomez-Lumbreras A; Prat-Vallverdú O; Quijada-Manuitt MA; Morros R
Aten Primaria; 2020 Oct; 52(8):529-538. PubMed ID: 32788057
[TBL] [Abstract][Full Text] [Related]
19. Higher persistence in newly diagnosed nonvalvular atrial fibrillation patients treated with dabigatran versus warfarin.
Zalesak M; Siu K; Francis K; Yu C; Alvrtsyan H; Rao Y; Walker D; Sander S; Miyasato G; Matchar D; Sanchez H
Circ Cardiovasc Qual Outcomes; 2013 Sep; 6(5):567-74. PubMed ID: 23922182
[TBL] [Abstract][Full Text] [Related]
20. Real-world persistence and adherence to oral anticoagulation for stroke risk reduction in patients with atrial fibrillation.
Beyer-Westendorf J; Ehlken B; Evers T
Europace; 2016 Aug; 18(8):1150-7. PubMed ID: 26830891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
